RETRACTED ARTICLE: The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma
2020 · Cell Death and Disease · 84 citations
https://doi.org/10.1038/s41419-020-03123-3
J
Jing Luo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
123
Papers
2.2K
Citations
27
h-index
50
i10-index
Jing Luo is an academic researcher from Yangtze University. The author has contributed to research in topics: Diabetes Management and Research & Pharmaceutical Economics and Policy & Diabetes Treatment and Management. The author has an h-index of 27, co-authored 105 publications.
ORCID: 0000-0002-1190-553XPapers by this author
worksAntiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004–2011
2014 · BMC Public Health · 33 citations
https://doi.org/10.1186/1471-2458-14-367
Free Sugars Intake among Chinese Adolescents and Its Association with Dental Caries: A Cross-Sectional Study
2021 · Nutrients · 28 citations
https://doi.org/10.3390/nu13030765
Buprenorphine dispensing before and after the April 2021 X-Waiver exemptions: An interrupted time series analysis
2024 · International Journal of Drug Policy · 28 citations
https://doi.org/10.1016/j.drugpo.2024.104381
MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1
2020 · Biochemical and Biophysical Research Communications · 16 citations
https://doi.org/10.1016/j.bbrc.2020.01.034
Human versus Analogue Insulin for Youth with Type 1 Diabetes in Low-Resource Settings (HumAn-1): protocol for a randomised controlled trial
2025 · BMJ Open · 4 citations
https://doi.org/10.1136/bmjopen-2024-092432
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat